Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
INSIGHT PROVIDER
Rising
Avien Pillay
Healthcare equity analyst - emerging & dev mkts
•
daaimon
Message
Follow
Location:
United Kingdom
Joined:
14 February 2024
14
Insights
4.7k
Views
14
Followers
Equity Bottom-Up
•
Thematic (Sector/Industry)
Message
Follow
Regions
Sectors
Verticals
More Filters
Refresh
Top Picks Only
Recent
bearish
•
Takeda Pharmaceutical
•
21 Jun 2024 01:51
Additional Points Add to Our Recent Bearish View on Takeda.
Additional points add to our recent bearish view on Takeda. We are particularly concerned about the psoriasis acquisition and restructuring.
Avien Pillay
445 Views
Share
bearish
•
Takeda Pharmaceutical
•
14 Jun 2024 08:00
Takeda (4502 JP)– Avoid
A potentially disappointing $6bn acquisition, high pipeline dropout, and limited probability of upside surprises sums up our analysis of expensive...
Avien Pillay
278 Views
Share
bullish
•
China Medical System
•
05 Jun 2024 18:54
UPDATE: China Medical System (CMS, 867 HK) – A Cheap Play on China’s Pending Health Care Crisis
A derating as a result of a transition period creates an excellent investment opportunity in a market that desperately needs to increase healthcare...
Avien Pillay
596 Views
Share
bullish
•
China Medical System
•
31 May 2024 08:30
China Medical System (CMS, 867 HK) – A Cheap Play on China’s Pending Health Care Crisis
A derating as a result of a transition period creates an excellent investment opportunity in a market that desperately needs to increase healthcare...
Avien Pillay
455 Views
Share
bullish
•
Thematic (Sector/Industry)
•
09 May 2024 18:53
Asian Healthcare Spend as a Percentage of GDP – the Laggards
China and especially India’s spend on healthcare lags several emerging markets and needs to drastically increase to address their critical...
Avien Pillay
187 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.1
x